NCT06809868RecruitingAccepts Healthy Volunteers

Role of Transposable Elements in Septic Immune Aging

University of California, San Francisco

Start Date

2/14/2025

Completion Date

8/14/2028

Summary

The goal of this observational study is to learn about how transposable element levels affect the patient outcomes in sepsis. The main questions it aims to answer is: 1. Do transposable elements prematurely age the immune systems of patients with sepsis? 2. Do transposable elements correlate with increased mortality in patients with sepsis in the ICU? 3. Do transposable elements correlate with increased amount of secondary infections in patients with sepsis in the ICU? Participants will have blood drawn from them but will not be subjected to additional interventions.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * Age 18 or older * Admitted to ICU with sepsis (Sepsis 3 Criteria) * SOFA score of at least 2 at time of enrollment Exclusion Criteria: * Patients on organ transplantation immunosuppression * Patients with preexisting leukopenia * Cancer patients receiving CAR-T therapy * Patients who are under 18 years of age or otherwise deemed pediatric * Patients with an ongoing bleeding diathesis (ie: DIC, hemorrhagic shock) * Patients with a chronic hemoglobin below 7.0 * Patients who, prior to their ICU admission, are blood transfusion dependent

Interventions

GENETIC

RNA and DNA Sequencing

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

SepsisSepsis and Septic ShockSepsis With Multiple Organ Dysfunction (MOD)Sepsis With Acute Organ DysfunctionSepsis, SevereSepsis at Intensive Care UnitSepsis, Severe Sepsis and Septic ShockSepsis, Septic Shock

Locations

University of California, San Francisco

San Francisco, California 94143

United States